Sibren van den Berg is the director of RARE-NL, a national platform that aims to accelerate the development and accessibility of therapies for rare diseases and through drug repurposing. His work focuses on strengthening the Dutch drug repurposing landscape by connecting academic, clinical, and regulatory stakeholders and actively advancing concrete repurposing cases. In addition, his PhD research at Amsterdam UMC focuses on the availability of drugs for rare diseases, with a particular emphasis on drug repurposing.
